Abstract
ABSTRACT: Increasingly, individuals are interested in genetic testing to find out if they are at increased risk for breast cancer and other diseases. Through direct-to-consumer genetic testing, people can receive information about many different traits, including some risk information about hereditary breast and ovarian cancer syndrome. With more people getting this information outside of the medical setting, clinicians should be aware of the benefits and limitations of such testing.